Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer

Author： Ikeguchi Masahide   Yamamoto Manabu   Arai Yosuke   Maeta Yoshihiko   Ashida Keigo   Katano Kuniyuki   Miki Yasunari   Kimura Takayuki  

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.2, Iss.2, 2011-03, pp. : 319-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancer

By Ueda Shinya   Hironaka Shuichi   Boku Narikazu   Fukutomi Akira   Yoshino Takayuki   Onozawa Yusuke  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 203-207

Springer Publishing Company

Access to resources Recommend Favorite

Should Patients with Advanced Colorectal Cancer be Treated with Chemotherapy?

By Blijham G.H.   Labianca R.   Bleiberg H.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 815-824

Elsevier

Access to resources Recommend Favorite

Phase II study of combined chemotherapy with irinotecan and S-1 (IRIS) plus bevacizumab in patients with inoperable recurrent or advanced colorectal cancer

By Komatsu Yoshito   Yuki Satoshi   Sogabe Susumu   Fukushima Hiraku   Nakatsumi Hiroshi   Kobayashi Yoshimitsu   Iwanaga Ichiro   Nakamura Michio   Hatanaka Kazuteru   Miyagishima Takuto   Kudo Mineo   Munakata Masaki   Meguro Takashi   Tateyama Miki   Sakata Yuh  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 867-872

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer

By Mazzeo F.   Berliere M.   Kerger J.   Squifflet J.   Duck L.   D'Hondt V.   Humblet Y.   Donnez J.   Machiels J.-P.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite

Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis

By Sakamoto Takeshi   Yasui Hirofumi   Boku Narikazu   Onozawa Yusuke   Hironaka Shuichi   Fukutomi Akira   Yamazaki Kentaro   Taku Keisei   Machida Nozomu   Todaka Akiko   Tomita Hideharu   Tsushima Takahiro   Taniguchi Hiroya   Hamauchi Satoshi  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 287-293

Springer Publishing Company

Access to resources Recommend Favorite